CSI FOCUS D-HF: THE FUTURE OF DEVICE-BASED THERAPIES AND DIAGNOSTICS FOR HEART FAILURE: THE CMO VIEW

CSI FOCUS D-HF: THE FUTURE OF DEVICE-BASED THERAPIES AND DIAGNOSTICS FOR HEART FAILURE: THE CMO VIEW (23:00 Beijing time / 16:00 CET, 23 April 2021 )

Philip Adamson（CMO, Abbott HF）, William Abraham（CMO, V-Wave）, Kenneth Stein（CMO, Boston Scientific CRM）, Robin Germany（CMO, Respicardia）, Todd Brinton（CMO, Edwards） : Live panel discussion